Cargando…
Human Wharton’s Jelly-Derived Mesenchymal Stromal Cells Primed by Tumor Necrosis Factor-α and Interferon-γ Modulate the Innate and Adaptive Immune Cells of Type 1 Diabetic Patients
The unique immunomodulation and immunosuppressive potential of Wharton’s jelly-derived mesenchymal stromal cells (WJ-MSCs) make them a promising therapeutic approach for autoimmune diseases including type 1 diabetes (T1D). The immunomodulatory effect of MSCs is exerted either by cell-cell contact or...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506215/ https://www.ncbi.nlm.nih.gov/pubmed/34650558 http://dx.doi.org/10.3389/fimmu.2021.732549 |
_version_ | 1784581690850541568 |
---|---|
author | Mrahleh, Mairvat Al- Matar, Suzan Jafar, Hanan Wehaibi, Suha Aslam, Nazneen Awidi, Abdalla |
author_facet | Mrahleh, Mairvat Al- Matar, Suzan Jafar, Hanan Wehaibi, Suha Aslam, Nazneen Awidi, Abdalla |
author_sort | Mrahleh, Mairvat Al- |
collection | PubMed |
description | The unique immunomodulation and immunosuppressive potential of Wharton’s jelly-derived mesenchymal stromal cells (WJ-MSCs) make them a promising therapeutic approach for autoimmune diseases including type 1 diabetes (T1D). The immunomodulatory effect of MSCs is exerted either by cell-cell contact or by secretome secretion. Cell-cell contact is a critical mechanism by which MSCs regulate immune-responses and generate immune regulatory cells such as tolerogenic dendritic cells (tolDCs) and regulatory T cell (Tregs). In this study, we primed WJ-MSCs with TNF-α and IFN-γ and investigated the immunomodulatory properties of primed WJ-MSCs on mature dendritic cells (mDCs) and activated T cells differentiated from mononuclear cells (MNCs) of T1D patient’s. Our findings revealed that primed WJ-MSCs impaired the antigen-mediated immunity, upregulated immune-tolerance genes and downregulated immune-response genes. We also found an increase in the production of anti-inflammatory cytokines and suppression of the production of pro-inflammatory cytokines. Significant upregulation of FOXP3, IL10 and TGFB1 augmented an immunosuppressive effect on adaptive T cell immunity which represented a strong evidence in support of the formation of Tregs. Furthermore, upregulation of many critical genes involved in the immune-tolerance mechanism (IDO1 and PTGES2/PTGS) was detected. Interestingly, upregulation of ENTPD1/NT5E genes express a strong evidence to switch immunostimulatory response toward immunoregulatory response. We conclude that WJ-MSCs primed by TNF-α and IFN-γ may represent a promising tool to treat the autoimmune disorders and can provide a new evidence to consider MSCs- based therapeutic approach for the treatment of TID. |
format | Online Article Text |
id | pubmed-8506215 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85062152021-10-13 Human Wharton’s Jelly-Derived Mesenchymal Stromal Cells Primed by Tumor Necrosis Factor-α and Interferon-γ Modulate the Innate and Adaptive Immune Cells of Type 1 Diabetic Patients Mrahleh, Mairvat Al- Matar, Suzan Jafar, Hanan Wehaibi, Suha Aslam, Nazneen Awidi, Abdalla Front Immunol Immunology The unique immunomodulation and immunosuppressive potential of Wharton’s jelly-derived mesenchymal stromal cells (WJ-MSCs) make them a promising therapeutic approach for autoimmune diseases including type 1 diabetes (T1D). The immunomodulatory effect of MSCs is exerted either by cell-cell contact or by secretome secretion. Cell-cell contact is a critical mechanism by which MSCs regulate immune-responses and generate immune regulatory cells such as tolerogenic dendritic cells (tolDCs) and regulatory T cell (Tregs). In this study, we primed WJ-MSCs with TNF-α and IFN-γ and investigated the immunomodulatory properties of primed WJ-MSCs on mature dendritic cells (mDCs) and activated T cells differentiated from mononuclear cells (MNCs) of T1D patient’s. Our findings revealed that primed WJ-MSCs impaired the antigen-mediated immunity, upregulated immune-tolerance genes and downregulated immune-response genes. We also found an increase in the production of anti-inflammatory cytokines and suppression of the production of pro-inflammatory cytokines. Significant upregulation of FOXP3, IL10 and TGFB1 augmented an immunosuppressive effect on adaptive T cell immunity which represented a strong evidence in support of the formation of Tregs. Furthermore, upregulation of many critical genes involved in the immune-tolerance mechanism (IDO1 and PTGES2/PTGS) was detected. Interestingly, upregulation of ENTPD1/NT5E genes express a strong evidence to switch immunostimulatory response toward immunoregulatory response. We conclude that WJ-MSCs primed by TNF-α and IFN-γ may represent a promising tool to treat the autoimmune disorders and can provide a new evidence to consider MSCs- based therapeutic approach for the treatment of TID. Frontiers Media S.A. 2021-09-28 /pmc/articles/PMC8506215/ /pubmed/34650558 http://dx.doi.org/10.3389/fimmu.2021.732549 Text en Copyright © 2021 Mrahleh, Matar, Jafar, Wehaibi, Aslam and Awidi https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Mrahleh, Mairvat Al- Matar, Suzan Jafar, Hanan Wehaibi, Suha Aslam, Nazneen Awidi, Abdalla Human Wharton’s Jelly-Derived Mesenchymal Stromal Cells Primed by Tumor Necrosis Factor-α and Interferon-γ Modulate the Innate and Adaptive Immune Cells of Type 1 Diabetic Patients |
title | Human Wharton’s Jelly-Derived Mesenchymal Stromal Cells Primed by Tumor Necrosis Factor-α and Interferon-γ Modulate the Innate and Adaptive Immune Cells of Type 1 Diabetic Patients |
title_full | Human Wharton’s Jelly-Derived Mesenchymal Stromal Cells Primed by Tumor Necrosis Factor-α and Interferon-γ Modulate the Innate and Adaptive Immune Cells of Type 1 Diabetic Patients |
title_fullStr | Human Wharton’s Jelly-Derived Mesenchymal Stromal Cells Primed by Tumor Necrosis Factor-α and Interferon-γ Modulate the Innate and Adaptive Immune Cells of Type 1 Diabetic Patients |
title_full_unstemmed | Human Wharton’s Jelly-Derived Mesenchymal Stromal Cells Primed by Tumor Necrosis Factor-α and Interferon-γ Modulate the Innate and Adaptive Immune Cells of Type 1 Diabetic Patients |
title_short | Human Wharton’s Jelly-Derived Mesenchymal Stromal Cells Primed by Tumor Necrosis Factor-α and Interferon-γ Modulate the Innate and Adaptive Immune Cells of Type 1 Diabetic Patients |
title_sort | human wharton’s jelly-derived mesenchymal stromal cells primed by tumor necrosis factor-α and interferon-γ modulate the innate and adaptive immune cells of type 1 diabetic patients |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506215/ https://www.ncbi.nlm.nih.gov/pubmed/34650558 http://dx.doi.org/10.3389/fimmu.2021.732549 |
work_keys_str_mv | AT mrahlehmairvatal humanwhartonsjellyderivedmesenchymalstromalcellsprimedbytumornecrosisfactoraandinterferongmodulatetheinnateandadaptiveimmunecellsoftype1diabeticpatients AT matarsuzan humanwhartonsjellyderivedmesenchymalstromalcellsprimedbytumornecrosisfactoraandinterferongmodulatetheinnateandadaptiveimmunecellsoftype1diabeticpatients AT jafarhanan humanwhartonsjellyderivedmesenchymalstromalcellsprimedbytumornecrosisfactoraandinterferongmodulatetheinnateandadaptiveimmunecellsoftype1diabeticpatients AT wehaibisuha humanwhartonsjellyderivedmesenchymalstromalcellsprimedbytumornecrosisfactoraandinterferongmodulatetheinnateandadaptiveimmunecellsoftype1diabeticpatients AT aslamnazneen humanwhartonsjellyderivedmesenchymalstromalcellsprimedbytumornecrosisfactoraandinterferongmodulatetheinnateandadaptiveimmunecellsoftype1diabeticpatients AT awidiabdalla humanwhartonsjellyderivedmesenchymalstromalcellsprimedbytumornecrosisfactoraandinterferongmodulatetheinnateandadaptiveimmunecellsoftype1diabeticpatients |